V. Turobov

Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis

A. Danilkovich, V. Lipkin, V. Turobov, 2018, Front. Pharmacol..

Immunosuppressant Peptide Abu-TGIRIS-Abu-NH2 and its Application for Treatment of Multiple Sclerosis

V. Lipkin, V. Turobov, A. Shevelev, 2018, BioNanoScience.

Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46–62

O. Favorova, N. Ponomarenko, A. Belogurov, 2009, Autoimmunity.

Prevention of experimental autoimmune encephalomyelitis in DA rats by grafting primary skin fibroblasts engineered to express transforming growth factor‐β1

V. Prassolov, Y. Chernajovsky, M. Sudomoina, 2004 .

Improvement of Cardiac Contractile Function in Rats with Postinfarction Cardiosclerosis after Transplantation of Mononuclear and Multipotent Stroma Bone Marrow Cells

V. Glinkina, I. Ilyushkina, D. V. Gol’dshtein, 2012, Bulletin of Experimental Biology and Medicine.

Temporal dynamics of cytokines in the blood of rats with experimentally induced autoimmune encephalomyelitis

E. Garanina, V. Turobov, A. Shevelev, 2017 .

Immunosuppressant Peptide Abu-TGIRIS-Abu-NH2 and its Application for Treatment of Multiple Sclerosis

V. Lipkin, V. Turobov, A. Shevelev, 2018, BioNanoScience.

C-Terminal Region of Caveolin-3 Contains a Stretch of Amino Acid Residues Capable of Diminishing Symptoms of Experimental Autoimmune Encephalomyelitis but Not Rheumatoid Arthritis Modeled in Rats

Y. Palikova, E. Shaykhutdinova, E. V. Navolotskaya, 2023, Biomedicines.